Oppenheimer Asset Management Inc. raised its position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 9.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,442 shares of the company’s stock after buying an additional 481 shares during the period. Oppenheimer Asset Management Inc.’s holdings in DocuSign were worth $338,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of the company. Inspire Investing LLC acquired a new stake in shares of DocuSign in the 3rd quarter valued at $911,000. Comerica Bank boosted its holdings in DocuSign by 228.8% during the first quarter. Comerica Bank now owns 28,901 shares of the company’s stock worth $1,721,000 after buying an additional 20,110 shares during the last quarter. International Assets Investment Management LLC boosted its stake in DocuSign by 5,660.8% during the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock worth $27,252,000 after acquiring an additional 431,295 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its holdings in DocuSign by 7.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after purchasing an additional 85,987 shares during the period. Finally, Carrera Capital Advisors acquired a new position in shares of DocuSign in the 3rd quarter valued at $666,000. Institutional investors and hedge funds own 77.64% of the company’s stock.
Insider Buying and Selling at DocuSign
In related news, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, September 16th. The stock was sold at an average price of $56.56, for a total value of $30,203.04. Following the completion of the sale, the director now directly owns 7,202 shares of the company’s stock, valued at approximately $407,345.12. This represents a 6.90 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 7,764 shares of the firm’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $69.95, for a total transaction of $543,091.80. Following the transaction, the chief executive officer now directly owns 107,825 shares in the company, valued at $7,542,358.75. The trade was a 6.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 69,558 shares of company stock valued at $4,272,768. Company insiders own 1.66% of the company’s stock.
DocuSign Price Performance
DocuSign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.17. The company had revenue of $736.03 million for the quarter, compared to the consensus estimate of $727.20 million. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.09 EPS. Equities research analysts expect that DocuSign, Inc. will post 1.01 EPS for the current year.
Wall Street Analysts Forecast Growth
Several research firms recently commented on DOCU. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday, September 6th. Citigroup upped their price objective on DocuSign from $86.00 to $87.00 and gave the stock a “buy” rating in a research note on Friday, September 6th. Wells Fargo & Company boosted their price objective on shares of DocuSign from $48.00 to $50.00 and gave the stock an “underweight” rating in a research note on Friday, September 6th. Royal Bank of Canada boosted their target price on DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a report on Friday, September 6th. Finally, Robert W. Baird raised their target price on shares of DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $63.40.
View Our Latest Stock Analysis on DocuSign
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- Why Are These Companies Considered Blue Chips?
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- What is the Australian Securities Exchange (ASX)
- Williams-Sonoma Stock: Buy It and Never Let It Go
- How to Evaluate a Stock Before Buying
- 5 Dividend ETFs to Buy and Hold Forever
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.